Illumina Inc (ILMN):企業の財務・戦略的SWOT分析

◆英語タイトル:Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1294
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Illumina Inc (ILMN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and for cancer. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The company sells its products through direct sales and distributors in the Americas, Asia-Pacific, Europe, the Middle East and Africa. Illumina is headquartered in San Diego, California, the US.

Illumina Inc Key Recent Developments

Mar 25,2020: Others : OptimizeRx Continues Coronavirus Conversation Series with Leaders of NextGen and Illumina
Feb 29,2020: MGI’s response to Illumina’s complaint
Feb 27,2020: Illumina files additional patent infringement suit against BGI in the U.S.
Feb 06,2020: Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
Feb 03,2020: Illumina Inc (ILMN) Files 10-K for the Fiscal Year Ended on December 31, 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Illumina Inc – Key Facts
Illumina Inc – Key Employees
Illumina Inc – Key Employee Biographies
Illumina Inc – Major Products and Services
Illumina Inc – History
Illumina Inc – Company Statement
Illumina Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Illumina Inc – Business Description
Product Category: Consumables
Overview
Performance
Product Category: Instruments
Overview
Performance
Product Category: Service and Other Revenue
Overview
Performance
Product Category: Microarray Products
Performance
Product Category: Sequencing Platforms
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia-Pacific (Excluding Greater China)
Performance
Geographical Segment: Europe, Middle East, and Africa
Performance
Geographical Segment: Greater China
Performance
R&D Overview
Illumina Inc – Corporate Strategy
Illumina Inc – SWOT Analysis
SWOT Analysis – Overview
Illumina Inc – Strengths
Illumina Inc – Weaknesses
Illumina Inc – Opportunities
Illumina Inc – Threats
Illumina Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Illumina Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Illumina Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Illumina Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 29, 2020: MGI’s response to Illumina’s complaint
Feb 06, 2020: Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
Jan 14, 2020: Roche signs 15-year deal with Illumina for cancer diagnostic
Jan 13, 2020: Illumina announces new sequencing system, partnership with Roche and Software Suite to Accelerate Adoption of Genomics
Jan 13, 2020: Genomics England and Illumina partner to deliver whole genome sequencing for England’s NHS Genomic Medicine Service
Jan 10, 2020: Illumina files patent infringement suits against BGI in Sweden and the United Kingdom
Dec 29, 2019: Illumina reports financial results for fourth quarter and fiscal year 2019
Oct 29, 2019: Illumina celebrates grand opening of its solutions center in the University of Maryland BioPark
Oct 24, 2019: Illumina reports financial results for third quarter of fiscal year 2019
Oct 09, 2019: Qiagen and Illumina sign 15-year deal for IVD tests
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Illumina Inc, Key Facts
Illumina Inc, Key Employees
Illumina Inc, Key Employee Biographies
Illumina Inc, Major Products and Services
Illumina Inc, History
Illumina Inc, Other Locations
Illumina Inc, Subsidiaries
Illumina Inc, Joint Venture
Illumina Inc, Key Competitors
Illumina Inc, Ratios based on current share price
Illumina Inc, Annual Ratios
Illumina Inc, Annual Ratios (Cont...1)
Illumina Inc, Annual Ratios (Cont...2)
Illumina Inc, Interim Ratios
Illumina Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Illumina Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Illumina Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Illumina Inc, Performance Chart (2015 - 2019)
Illumina Inc, Ratio Charts
Illumina Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Illumina Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Illumina Inc (ILMN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Real Estate Company K.S.C.:企業の戦略・SWOT・財務情報
    National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report Summary National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Itochu Techno-Solutions Corp (4739):企業の財務・戦略的SWOT分析
    Itochu Techno-Solutions Corp (4739) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • LIncoln Electric Holdings Inc:企業のM&A・事業提携・投資動向
    LIncoln Electric Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LIncoln Electric Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Halt Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Halt Medical Inc (Halt Medical) is a healthcare service center that develops, manufactures and commercializes medical treatment for women with symptomatic uterine fibroids. The center offers Acessa System, a minimally invasive laparoscopic outpatient procedure to treat uterine fibroids. It o …
  • Oil India Limited:企業の戦略・SWOT・財務分析
    Oil India Limited - Strategy, SWOT and Corporate Finance Report Summary Oil India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The GPT Group (GPT):企業の財務・戦略的SWOT分析
    The GPT Group (GPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Samsung Heavy Industries Co., Ltd.
    Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Verax Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Verax Biomedical Inc (Verax) is a developer of rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company’s products include platelet pgd test, red cell pgd test and cell therapy PGD test. It uses the PGD tech …
  • The Real Good Food Company plc:企業の戦略・SWOT・財務情報
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Repsol Sinopec Resources UK Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Repsol Sinopec Resources UK Ltd (Repsol Sinopec), formerly Talisman Sinopec Energy UK Ltd is an oil and gas company that offers exploration services. The company explores, discovers, and produces oil and gas across the North Sea. It provides operation in floating facilities, offshore platfor …
  • Owens & Minor, Inc.:企業の戦略・SWOT・財務情報
    Owens & Minor, Inc. - Strategy, SWOT and Corporate Finance Report Summary Owens & Minor, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • AJ Lucas Group Ltd (AJL)-石油・ガス分野:企業M&A・提携分析
    Summary AJ Lucas Group Ltd (Lucas) is a provider of engineering, construction and drilling services. The company offers drilling, construction and civil engineering, project management, infrastructure related services for pipelines and other professional engineering services. It is also a supplier o …
  • Computer Services, Inc (CSVI):企業の財務・戦略的SWOT分析
    Computer Services, Inc (CSVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • DaVita Inc.:企業の戦略・SWOT・財務情報
    DaVita Inc. - Strategy, SWOT and Corporate Finance Report Summary DaVita Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • STP&I Public Company Limited:企業の戦略・SWOT・財務情報
    STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • GUD Holdings Limited (GUD):企業の財務・戦略的SWOT分析
    GUD Holdings Limited (GUD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • W. L. Gore & Associates Inc:企業の戦略的SWOT分析
    W. L. Gore & Associates Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Insys Therapeutics Inc (INSY)-製薬・医療分野:企業M&A・提携分析
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead prod …
  • CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆